Light chain deposition disease (LCDD) is a monoclonal gammopathy of clinical significance1 that is characterized by the formation of unstructured tissue deposits of the monoclonal immunoglobulin light chain. The kidney is involved in almost all patients. Renal involvement results in proteinuria, hypertension, and microhematuria. The clonal plasma cell infiltrate is usually small (<10% in ∼85% of patients).2 In the absence of an effective therapy, the disease progresses to chronic kidney failure, eventually requiring renal replacement therapy.3-6

Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function

Rizzi, Rita;Guido, Raffaella;Gesualdo, Loreto;Specchia, Giorgina;
2020-01-01

Abstract

Light chain deposition disease (LCDD) is a monoclonal gammopathy of clinical significance1 that is characterized by the formation of unstructured tissue deposits of the monoclonal immunoglobulin light chain. The kidney is involved in almost all patients. Renal involvement results in proteinuria, hypertension, and microhematuria. The clonal plasma cell infiltrate is usually small (<10% in ∼85% of patients).2 In the absence of an effective therapy, the disease progresses to chronic kidney failure, eventually requiring renal replacement therapy.3-6
File in questo prodotto:
File Dimensione Formato  
2020_Milani_Blood Adv.pdf

accesso aperto

Tipologia: Documento in Versione Editoriale
Licenza: Creative commons
Dimensione 707.49 kB
Formato Adobe PDF
707.49 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/266667
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 22
social impact